ClinVar Miner

Submissions for variant NM_000019.4(ACAT1):c.655T>C (p.Tyr219His)

dbSNP: rs1437567292
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department of Pediatrics, Gifu University RCV000844798 SCV000966074 likely pathogenic Deficiency of acetyl-CoA acetyltransferase 2019-05-05 criteria provided, single submitter research
Labcorp Genetics (formerly Invitae), Labcorp RCV000844798 SCV004296135 likely pathogenic Deficiency of acetyl-CoA acetyltransferase 2023-10-26 criteria provided, single submitter clinical testing This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 219 of the ACAT1 protein (p.Tyr219His). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This missense change has been observed in individual(s) with ACAT1-related conditions (PMID: 17236799; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 666492). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ACAT1 protein function. Experimental studies have shown that this missense change affects ACAT1 function (PMID: 17236799). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Baylor Genetics RCV000844798 SCV005059106 likely pathogenic Deficiency of acetyl-CoA acetyltransferase 2023-11-14 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000844798 SCV005423522 likely pathogenic Deficiency of acetyl-CoA acetyltransferase 2024-10-02 criteria provided, single submitter clinical testing Variant summary: ACAT1 c.655T>C (p.Tyr219His) results in a conservative amino acid change located in the Thiolase, N-terminal domain (IPR020616) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251310 control chromosomes. c.655T>C has been reported in the literature in the presumed compound heterozygous state in at least 1 individual affected with acetoacetyl-CoA thiolase (T2) deficiency (example, Sakurai_2007). At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity in fibroblasts (example, Sakurai_2007). The following publication has been ascertained in the context of this evaluation (PMID: 17236799). ClinVar contains an entry for this variant (Variation ID: 666492). Based on the evidence outlined above, the variant was classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.